Epidemiological Study for Urologic Cancer in Korea (1998-2002).
- Author:
Wun Jae KIM
1
;
Jae Il CHUNG
;
Jun Hyuk HONG
;
Choung Soo KIM
;
Se Il JUNG
;
Duck Ki YOON
Author Information
1. Department of Urology, Chungbuk National University College of Medicine, Korea. wjkim@med.chungbuk.ac.kr
- Publication Type:Original Article
- Keywords:
Urologic cancer;
Incidence
- MeSH:
Carcinoma, Renal Cell;
Epidemiologic Studies*;
Female;
Hope;
Humans;
Incidence;
Kidney;
Kidney Pelvis;
Korea*;
Male;
Prevalence;
Prostate;
Testicular Neoplasms;
Testis;
Ureter;
Urinary Bladder;
Urinary Bladder Neoplasms;
Urologic Neoplasms*
- From:Korean Journal of Urology
2004;45(11):1081-1088
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To evaluate the incidence of urologic cancer in Korea. MATERIALS AND METHODS: Between January 1998 and December 2002 the Korean Urologic Oncology Society (KUOS) decided to evaluate the incidence of Korean urologic cancer. The URO-DMS data obtained by 86 training hospital was analyzed. First, the disease code was simplified; for example, renal cell carcinoma (C64), and thereafter, evaluated for incidence and prevalence, etc. RESULTS: A total of 35,480 patients were newly diagnosed over this period. Bladder cancer was the most common (42.9%) urologic cancer, followed by prostate (26.4%), kidney (22.4%), ureter (3.7%), renal pelvis (3.0%), testis (2.8%), penile (0.2%), urethral (0.1%) and scrotal cancers (0.1%). Male patients outnumbered the females by a ratio of 4.4:1. The incidence rates per 100,000 males for prostate and testicular cancers were 7.73 and 0.81, respectively. The incidence rates per 100,000 persons for bladder, renal, ureter and renal pelvis cancers were 6.36, 3.30, 0.55 and 0.44, respectively. Cancers of the prostate and kidney increased rapidly, but the others increased steadily. CONCLUSIONS: It is hoped that these results would contribute to cancer research and control of cancers in Korea.
